Safety of shrimp peptide concentrate as a novel food pursuant to Regulation (EU) 2015/2283
Abstract Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on shrimp peptide concentrate as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is a peptide mixture obtained by an enzymatic...
Published in: | EFSA Journal |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Wiley
2018
|
Subjects: | |
Online Access: | https://doi.org/10.2903/j.efsa.2018.5267 https://doaj.org/article/a6d2a54b7bfb4fc28a2bf5d632666bd7 |
id |
ftdoajarticles:oai:doaj.org/article:a6d2a54b7bfb4fc28a2bf5d632666bd7 |
---|---|
record_format |
openpolar |
spelling |
ftdoajarticles:oai:doaj.org/article:a6d2a54b7bfb4fc28a2bf5d632666bd7 2023-05-15T17:43:56+02:00 Safety of shrimp peptide concentrate as a novel food pursuant to Regulation (EU) 2015/2283 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Dominique Turck Jean‐Louis Bresson Barbara Burlingame Tara Dean Susan Fairweather‐Tait Marina Heinonen Karen Ildico Hirsch‐Ernst Inge Mangelsdorf Harry J McArdle Androniki Naska Monika Neuhäuser‐Berthold Grażyna Nowicka Kristina Pentieva Yolanda Sanz Alfonso Siani Anders Sjödin Martin Stern Daniel Tomé Marco Vinceti Peter Willatts Karl‐Heinz Engel Rosangela Marchelli Annette Pöting Morten Poulsen Josef Rudolf Schlatter Leonard Matijević Henk van Loveren 2018-05-01T00:00:00Z https://doi.org/10.2903/j.efsa.2018.5267 https://doaj.org/article/a6d2a54b7bfb4fc28a2bf5d632666bd7 EN eng Wiley https://doi.org/10.2903/j.efsa.2018.5267 https://doaj.org/toc/1831-4732 1831-4732 doi:10.2903/j.efsa.2018.5267 https://doaj.org/article/a6d2a54b7bfb4fc28a2bf5d632666bd7 EFSA Journal, Vol 16, Iss 5, Pp n/a-n/a (2018) shrimps (Pandalus borealis) bioactive peptides ACE‐inhibitors novel food safety Nutrition. Foods and food supply TX341-641 Chemical technology TP1-1185 article 2018 ftdoajarticles https://doi.org/10.2903/j.efsa.2018.5267 2022-12-31T06:46:56Z Abstract Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on shrimp peptide concentrate as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is a peptide mixture obtained by an enzymatic proteolysis from northern shrimp (Pandalus borealis) shells and heads. The information provided on the composition, specifications, batch‐to‐batch variability, stability and production process of the NF is sufficient and does not raise safety concerns. The intention of the applicant is to use this NF as an ingredient in food supplements and to market it to adult consumers at a maximum proposed level of intake of 1,200 mg/day (corresponding to 17 mg/kg body weight (bw) per day for a 70 kg person). There are no concerns with regard to genotoxicity. The available human data do not raise safety concerns. Considering the no observed adverse effect level (NOAEL) of 2,000 mg/kg bw per day from a 90‐day repeated‐dose oral toxicity study, the maximum proposed level of intake and the nature of the NF, the Panel concludes that the margin of exposure (of 117) is sufficient. The Panel concludes that the NF, shrimp peptide concentrate, is safe to be used as a food supplement at the proposed maximum dose of 1,200 mg/day. The target population is adults. The Panel considered that the conclusion on the safety of the NF could not have been reached without the data from the unpublished study report on repeated‐dose 90‐day oral toxicity and from the unpublished study reports on two human studies. Article in Journal/Newspaper northern shrimp Pandalus borealis Directory of Open Access Journals: DOAJ Articles EFSA Journal 16 5 |
institution |
Open Polar |
collection |
Directory of Open Access Journals: DOAJ Articles |
op_collection_id |
ftdoajarticles |
language |
English |
topic |
shrimps (Pandalus borealis) bioactive peptides ACE‐inhibitors novel food safety Nutrition. Foods and food supply TX341-641 Chemical technology TP1-1185 |
spellingShingle |
shrimps (Pandalus borealis) bioactive peptides ACE‐inhibitors novel food safety Nutrition. Foods and food supply TX341-641 Chemical technology TP1-1185 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Dominique Turck Jean‐Louis Bresson Barbara Burlingame Tara Dean Susan Fairweather‐Tait Marina Heinonen Karen Ildico Hirsch‐Ernst Inge Mangelsdorf Harry J McArdle Androniki Naska Monika Neuhäuser‐Berthold Grażyna Nowicka Kristina Pentieva Yolanda Sanz Alfonso Siani Anders Sjödin Martin Stern Daniel Tomé Marco Vinceti Peter Willatts Karl‐Heinz Engel Rosangela Marchelli Annette Pöting Morten Poulsen Josef Rudolf Schlatter Leonard Matijević Henk van Loveren Safety of shrimp peptide concentrate as a novel food pursuant to Regulation (EU) 2015/2283 |
topic_facet |
shrimps (Pandalus borealis) bioactive peptides ACE‐inhibitors novel food safety Nutrition. Foods and food supply TX341-641 Chemical technology TP1-1185 |
description |
Abstract Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on shrimp peptide concentrate as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is a peptide mixture obtained by an enzymatic proteolysis from northern shrimp (Pandalus borealis) shells and heads. The information provided on the composition, specifications, batch‐to‐batch variability, stability and production process of the NF is sufficient and does not raise safety concerns. The intention of the applicant is to use this NF as an ingredient in food supplements and to market it to adult consumers at a maximum proposed level of intake of 1,200 mg/day (corresponding to 17 mg/kg body weight (bw) per day for a 70 kg person). There are no concerns with regard to genotoxicity. The available human data do not raise safety concerns. Considering the no observed adverse effect level (NOAEL) of 2,000 mg/kg bw per day from a 90‐day repeated‐dose oral toxicity study, the maximum proposed level of intake and the nature of the NF, the Panel concludes that the margin of exposure (of 117) is sufficient. The Panel concludes that the NF, shrimp peptide concentrate, is safe to be used as a food supplement at the proposed maximum dose of 1,200 mg/day. The target population is adults. The Panel considered that the conclusion on the safety of the NF could not have been reached without the data from the unpublished study report on repeated‐dose 90‐day oral toxicity and from the unpublished study reports on two human studies. |
format |
Article in Journal/Newspaper |
author |
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Dominique Turck Jean‐Louis Bresson Barbara Burlingame Tara Dean Susan Fairweather‐Tait Marina Heinonen Karen Ildico Hirsch‐Ernst Inge Mangelsdorf Harry J McArdle Androniki Naska Monika Neuhäuser‐Berthold Grażyna Nowicka Kristina Pentieva Yolanda Sanz Alfonso Siani Anders Sjödin Martin Stern Daniel Tomé Marco Vinceti Peter Willatts Karl‐Heinz Engel Rosangela Marchelli Annette Pöting Morten Poulsen Josef Rudolf Schlatter Leonard Matijević Henk van Loveren |
author_facet |
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Dominique Turck Jean‐Louis Bresson Barbara Burlingame Tara Dean Susan Fairweather‐Tait Marina Heinonen Karen Ildico Hirsch‐Ernst Inge Mangelsdorf Harry J McArdle Androniki Naska Monika Neuhäuser‐Berthold Grażyna Nowicka Kristina Pentieva Yolanda Sanz Alfonso Siani Anders Sjödin Martin Stern Daniel Tomé Marco Vinceti Peter Willatts Karl‐Heinz Engel Rosangela Marchelli Annette Pöting Morten Poulsen Josef Rudolf Schlatter Leonard Matijević Henk van Loveren |
author_sort |
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |
title |
Safety of shrimp peptide concentrate as a novel food pursuant to Regulation (EU) 2015/2283 |
title_short |
Safety of shrimp peptide concentrate as a novel food pursuant to Regulation (EU) 2015/2283 |
title_full |
Safety of shrimp peptide concentrate as a novel food pursuant to Regulation (EU) 2015/2283 |
title_fullStr |
Safety of shrimp peptide concentrate as a novel food pursuant to Regulation (EU) 2015/2283 |
title_full_unstemmed |
Safety of shrimp peptide concentrate as a novel food pursuant to Regulation (EU) 2015/2283 |
title_sort |
safety of shrimp peptide concentrate as a novel food pursuant to regulation (eu) 2015/2283 |
publisher |
Wiley |
publishDate |
2018 |
url |
https://doi.org/10.2903/j.efsa.2018.5267 https://doaj.org/article/a6d2a54b7bfb4fc28a2bf5d632666bd7 |
genre |
northern shrimp Pandalus borealis |
genre_facet |
northern shrimp Pandalus borealis |
op_source |
EFSA Journal, Vol 16, Iss 5, Pp n/a-n/a (2018) |
op_relation |
https://doi.org/10.2903/j.efsa.2018.5267 https://doaj.org/toc/1831-4732 1831-4732 doi:10.2903/j.efsa.2018.5267 https://doaj.org/article/a6d2a54b7bfb4fc28a2bf5d632666bd7 |
op_doi |
https://doi.org/10.2903/j.efsa.2018.5267 |
container_title |
EFSA Journal |
container_volume |
16 |
container_issue |
5 |
_version_ |
1766146114136834048 |